SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

SUPN

Supernus Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 37.88 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 3, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 3, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,12315 flagged findings
Reported transactions (Form 4)80since Feb 24, 2026 · and 11 other holdings
Corporate events (8-K)30since Oct 5, 2020

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-05regulatory investigationrecentOpen filing ↗
    “…support of their motion is due by September 22, 2026. Related derivative actions remain stayed pending the resolution of this…”
    +1 more passage from the same document
    • “…to dismiss is due by August 31, 2026, and Defendants’ reply in further support of their motion is due by September 22, 2026.…”
  • 2026-05-05merger or acquisition eventrecentOpen filing ↗
    “…among other things, the removal of the annual minimum purchase requirement of MYOBLOC, and the Company's agreement to pay a…”
    +1 more passage from the same document
    • “…the Consolidated Financial Statements in Part I, Item 1, Unaudited Condensed Consolidated Financial Statements, of this Quarterly…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,123)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 15, 268-K ↗Current report · Shareholder vote results new
  • Oct 6, 26Form 425 ↗Merger, acquisition or tender offer
  • Oct 6, 26DEFA14A ↗Shareholder meeting and votes
  • Sep 11, 26DEFM14A ↗Shareholder meeting and votes
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Aug 6, 26SCHEDULE 13G/A ↗Passive stake · Millennium Management LLC · 6.6% · event on Jun 30, 26 · amendment
  • Aug 4, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 2610-Q ↗Quarterly report
  • Aug 3, 268-K ↗Current report · Results
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Other events
  • Aug 3, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Other events
  • Aug 3, 26DEFA14A ↗Shareholder meeting and votes
  • Aug 3, 26Form 425 ↗Merger, acquisition or tender offer
  • Aug 3, 268-K ↗Current report · Entered a material agreement
  • Insider transaction · 2 Form 4 filingsshow all 2hide

1,123 filings on record, the oldest from Apr 30, 12.

Listing the 25 most recent filings of the 1,123 on record.

8-Ks, explained

Stress4Structure37Governance37
  • Aug 3, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • May 20, 26StructureTook on a new financial obligation+1 more in the same filing8-K 2.03 ↗
  • Apr 7, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 24, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 4, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jul 31, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jun 16, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance5 senior executive changes2023 – 2025show all 5hide
    • Feb 24, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Apr 24, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Feb 28, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 21, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Aug 21, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jun 23, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Apr 3, 23StructureTook on a new financial obligation+1 more in the same filing8-K 2.03 ↗
  • Mar 1, 23GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Feb 14, 23StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗

10 older filings not shown · The record reaches back to Jun 29, 12.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Mar 21, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jan 16, 18StressListing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
  • Nov 18, 16StressListing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
  • Nov 14, 16StressPast accounts declared unreliable and being restated+2 more in the same filing8-K 4.02 ↗

The full record holds 4 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.14.7%Mar 31, 25SCHEDULE 13G/A ↗
  • Millennium Management LLC6.6%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Vanguard Portfolio Management5.7%Mar 31, 26SCHEDULE 13G ↗
  • Vanguard Capital Management5.0%Mar 31, 26SCHEDULE 13G ↗
  • Armistice Capital, LLC4.8%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
show one more holderhide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Mar 18, 26Sell$339KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 18, 26Sell$21KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 17, 26Sell$1.4MPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 17, 26Sell$1.1MPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Sell$1.7MPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Sell$802KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 13, 26Sell$1.2MJack A. KhattarPresident, CEO↗
  • Mar 13, 26Sell$548KJack A. KhattarPresident, CEO↗
  • Mar 13, 26Sell$6KJack A. KhattarPresident, CEO↗
  • Mar 12, 26Sell$272KFrederick M. Hudson↗
  • Mar 10, 26Sell$244KWilliam Todd HorichSVP, Commercial Operations↗
  • Mar 9, 26Sell$87KFrank MottolaSVP, Chief Tech. Ops. Officer↗

There are 2 more transactions in this stretch.

Stock compensation, tax and giftsshow the 26 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Aug 12, 26Compensationamount n/aTIMOTHY C DECSenior Vice-President & CFO↗
  • Aug 12, 26Tax$28KTIMOTHY C DECSenior Vice-President & CFO↗
  • Aug 12, 26Compensationamount n/aPadmanabh P. BhattSr. VP of IP, CSO↗
  • Aug 12, 26Tax$54KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Aug 12, 26Compensationamount n/aJack A. KhattarPresident, CEO↗
  • Aug 12, 26Tax$589KJack A. KhattarPresident, CEO↗
  • Aug 12, 26Compensationamount n/aFrank MottolaSVP, Chief Tech. Ops. Officer↗
  • Aug 12, 26Tax$37KFrank MottolaSVP, Chief Tech. Ops. Officer↗
  • Aug 12, 26Compensationamount n/aJonathan RubinSVP, Chief Medical Officer↗
  • Aug 12, 26Tax$17KJonathan RubinSVP, Chief Medical Officer↗
  • Mar 18, 26Compensation$286KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 17, 26Compensation$896KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 17, 26Compensation$450KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 17, 26Compensation$579KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Compensation$836KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Compensation$126KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Compensation$580KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 16, 26Compensation$140KPadmanabh P. BhattSr. VP of IP, CSO↗
  • Mar 13, 26Otheramount n/aJack A. KhattarPresident, CEO↗
  • Mar 13, 26Otheramount n/aJack A. KhattarPresident, CEO↗
  • Mar 6, 26Compensation$200KGEORGES GEMAYEL↗
  • Mar 6, 26Compensationamount n/aJack A. KhattarPresident, CEO↗
  • Mar 6, 26Tax$907KJack A. KhattarPresident, CEO↗
  • Mar 6, 26Compensationamount n/aFrank MottolaSVP, Chief Tech. Ops. Officer↗
  • Mar 6, 26Tax$98KFrank MottolaSVP, Chief Tech. Ops. Officer↗
  • Mar 6, 26Compensationamount n/aWilliam Todd HorichSVP, Commercial Operations↗

The full record holds 356 transactions and goes back to Apr 17, 18.

Its sector and its market

Supernus Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Supernus Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Supernus Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,123 documents on file, from Apr 30, 2012 to Oct 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.